Healthcare Business Review
About UsConferencePartner With Us
  • Patient Care
    Dental Billing Services
    Medical Case Management
    Medical Transportation
    Multi Speciality
    Pathology Services
    Patient Monitoring
    Pharmacy Service
    Telemedicine Services
    Therapy Services
    Veterinary Services
  • Operations
    Business Process Outsourcing
    Consulting Services
    Financial Services
    Health Insurance
    Healthcare Education
    Healthcare Marketing
    Healthcare Staffing
    Medical Billing
    Practice Management Services
  • Infrastructure
    Compliance & Risk Management
    Facility Management Services
    Healthcare Procurement
    Healthcare Security
    Healthcare Services
    Medical Equipment Repair & Maintenance
    Real Estate Services
    Supply Chain
  • Leadership Perspectives
  • Insights
  • Research
  • News
  • Magazines
  • CXO Awards
    • US
      • US
      • EUROPE
      • APAC
      • CANADA
      • LATAM
×
#

Healthcare Business Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Healthcare Business Review

Subscribe

loading

NeuroRelief has been recognized by Healthcare Business Review Magazine as the exclusive recipient of “Top 10 Addiction Treatment Companies - 2024,” based on our proprietary methodology, reflecting its position in the industry. This profile has been developed by the Healthcare Business Review research and editorial team based on insights from an interview with Dr. Austin Harris, Owner.

NeuroRelief
Treating Addiction with Empathy and Evidence

NeuroRelief

Dr. Austin Harris, NeuroRelief | Healthcare Business Review | Top Addiction Treatment CompaniesDr. Austin Harris, Owner
Anesthesiologist Dr. Austin Harris made a groundbreaking discovery in addiction treatment when he learned the transformative use of ketamine—a common surgical anesthetic—in treating substance use disorder.

This set him on a path of innovation, leading to the establishment of NeuroReliefTM Ketamine & Infusion Therapy. Today, this clinic specializing in ketamine infusion therapy is poised to offer a lifeline to those seeking to break free from the chains of drug and alcohol dependency.

“At NeuroReliefTM, our innovative addiction recovery program steps away from the cookie-cutter approach. We understand that the roots of addiction often arise from mood disorders, chronic pain and unresolved trauma. That’s why we adopt a method that is as empathetic as it is evidence-based, crafting a customized, integrative, and multimodal treatment plan that respects each patient’s individuality,” says Dr. Harris, owner.

Consider the stirring narrative of a 21-year-old young man, addicted to fentanyl. His family’s relentless quest for his recovery seemed to falter at every turn until NeuroReliefTM extended a hand. Within the span of two transformative weeks of ketamine infusion therapy, combined with nicotinamide adenine dinucleotide (NAD+ ) infusion therapy and additional integrative methods of support, his life’s trajectory shifted profoundly. Not only did he step back from the brink of addiction, but he reclaimed his aspirations and re-enrolled in school, embarking on a meaningful career path. Today, Dr. Harris’s conversations with his parents are filled with humility and deep-seated gratitude.

It’s stories like this that illuminate the heart of NeuroRelief’s mission. Integrating evidence-based therapies with the trifecta of mind-body-soul wellness helps individuals heal faster from within. The goal is not just to achieve sobriety but to foster lasting recovery and help reconnect with themselves while living a fulfilling life free from the grip of addiction.

This holistic vision is epitomized by Dr. Harris’s initial two-hour, one-on-one intake session with every individual walking through the doors of his clinic. The immersive dialog is far from a cursory assessment. It is a deep and empathetic exploration into the patient’s lifelong narrative, from childhood to their current crossroads. Such thorough understanding uncovers the complex experiences, underlying traumas and biological intricacies that forge the chains of addiction.

Following the consultations, NeuroReliefTM tailors a therapeutic regimen for ketamine and NAD+ infusions that aligns with the patient’s distinct neurological makeup. These treatments are continually adjusted, moment by-moment, during each session to optimize the neurologic and experiential benefit of each treatment.

Over time, patients can see visible improvements in addressing the four drivers of addiction. First, it works by blocking glutamate receptors and disrupts the reward pathway associated with withdrawal and cravings for substantial abuse. It simultaneously resets the natural reward system, responsible for the sense of fulfillment individuals get from healthy daily stimuli. Recovery of these reward instincts can take many years, but NeuroRelief’s ketamine infusions act like a circuit breaker, quickly bringing color back into a person’s daily life experience. This rapid return to normalcy reduces the need for the individual to relapse.

We understand that the roots of addiction often arise from mood disorders, chronic pain, and unresolved trauma. That’s why we adopt a method that is as empathetic as it is evidence-based, crafting a customized, integrative, and multimodal treatment plan that respects each patient’s individuality

The use of ketamine not only aids in breaking the cycle of addiction but enhances neuroplasticity, allowing individuals to form new neural connections and acquire coping strategies. It also serves as an emotional ‘janitorial system,’ enabling the subconscious to process trauma without overwhelming emotions, leaving patients feeling lighter and more capable of investing in their own well being.

Combining ketamine infusions with NAD+ also plays a crucial role in reoptimizing mitochondrial energy production within cells often depleted by addiction. Their dual influence results in profound gains in cognitive clarity and improving symptoms of various chronic conditions like depression, mind fog, chronic fatigue syndrome and premature aging. Revitalizing mental and physical health, NeuroReliefTM provides individuals with a new lease on life. NAD+ infusions also significantly decrease craving and withdrawal symptoms in those actively detoxing or weaning from drugs and/or alcohol. Together, NAD+ and ketamine have a synergistic benefit response for each patient. These specific protocols at NeuroReliefTM do not exist at any other clinic in the world and are patent pending.

This commitment to stimulating behavioral health is complemented by its certified integration and recovery coaching. From mindful cognitive behavioral technique (CBT) and mindfulness meditation sessions to medication management, the program focuses on helping patients build resilience against relapse. Individuals are given this transformational support in a safe and comfortable environment, conducted on every treatment day after the infusion, over the watchful eye of a care team, who guides them throughout their journey to recovery. This integrative process doesn’t just help a client reach sobriety but builds the foundation for a lifestyle, neurologically and psychologically, for the client to find increased reward and well-being in their daily life in general.

The efficacy of this approach is not just hopeful; it’s proven. With an impressive 83 percent of patients maintaining sobriety at the six-month mark, NeuroReliefTM soars beyond the industry average of 10 percent. This remarkable success rate indicates the clinic’s revolutionary impact, heralding a new era where individuals are not only surviving but thriving as they tread the path to a healthier, more fulfilling life.

Top 10 Addiction Treatment Companies - 2024
Current Issue

Company :NeuroRelief

Management

Dr. Austin Harris, Owner

Thank you for Subscribing to Healthcare Business Review Weekly Brief

Healthcare Business Review
Follow on LinkedIn

About

  • Home
  • About Us
  • Partner With Us

Stay Connected

  • Subscribe
  • Newsletter
  • Sitemap

Contact Us

  • editorial@healthcarebusinessreview.com
  • salesus@healthcarebusinessreview.com
  • marketingus@healthcarebusinessreview.com

Legal

  • Editorial Policy
  • Privacy Policy
  • Terms of Use

© 2026 Healthcare Business Review . All rights reserved. Headquarteblue in Fort Lauderdale, FL, USA.

CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.healthcarebusinessreview.com/neurorelief